O papel governamental como ator essencial para a P&D de medicamentos: um estudo de casos

Detalhes bibliográficos
Autor(a) principal: Marinho,Vera Maria Costa
Data de Publicação: 2008
Outros Autores: Seidl,Peter Rudolf, Longo,Waldimir Pirró e
Tipo de documento: Artigo
Idioma: por
Título da fonte: Química Nova (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422008000700055
Resumo: The importance of natural products as a source of new high value-added drugs has, no doubt, transformed Brazilian megadiversity into one of the country's most valuable and strategic assets. Thus the rational exploration of the Brazilian flora on an economic basis should be considered as part of a national development strategy. In this respect, governmental mechanisms to stimulate regulation on the access, bioprospection and industrial use of natural products represent a crucial issue. The aim of this paper is to show how the incentives and institutional arrangements that led to one of the greatest breakthroughs in the pharmaceutical industry, the development and commercialization of the anti-cancer agent Taxol, could be applied to the Brazilian case.
id SBQ-3_b766355cead7e29d3d1e224d5eeb34c6
oai_identifier_str oai:scielo:S0100-40422008000700055
network_acronym_str SBQ-3
network_name_str Química Nova (Online)
repository_id_str
spelling O papel governamental como ator essencial para a P&D de medicamentos: um estudo de casospharmaceutical R&Dgovernment incentivesTaxolThe importance of natural products as a source of new high value-added drugs has, no doubt, transformed Brazilian megadiversity into one of the country's most valuable and strategic assets. Thus the rational exploration of the Brazilian flora on an economic basis should be considered as part of a national development strategy. In this respect, governmental mechanisms to stimulate regulation on the access, bioprospection and industrial use of natural products represent a crucial issue. The aim of this paper is to show how the incentives and institutional arrangements that led to one of the greatest breakthroughs in the pharmaceutical industry, the development and commercialization of the anti-cancer agent Taxol, could be applied to the Brazilian case.Sociedade Brasileira de Química2008-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422008000700055Química Nova v.31 n.7 2008reponame:Química Nova (Online)instname:Sociedade Brasileira de Química (SBQ)instacron:SBQ10.1590/S0100-40422008000700055info:eu-repo/semantics/openAccessMarinho,Vera Maria CostaSeidl,Peter RudolfLongo,Waldimir Pirró epor2008-12-09T00:00:00Zoai:scielo:S0100-40422008000700055Revistahttps://www.scielo.br/j/qn/ONGhttps://old.scielo.br/oai/scielo-oai.phpquimicanova@sbq.org.br1678-70640100-4042opendoar:2008-12-09T00:00Química Nova (Online) - Sociedade Brasileira de Química (SBQ)false
dc.title.none.fl_str_mv O papel governamental como ator essencial para a P&D de medicamentos: um estudo de casos
title O papel governamental como ator essencial para a P&D de medicamentos: um estudo de casos
spellingShingle O papel governamental como ator essencial para a P&D de medicamentos: um estudo de casos
Marinho,Vera Maria Costa
pharmaceutical R&D
government incentives
Taxol
title_short O papel governamental como ator essencial para a P&D de medicamentos: um estudo de casos
title_full O papel governamental como ator essencial para a P&D de medicamentos: um estudo de casos
title_fullStr O papel governamental como ator essencial para a P&D de medicamentos: um estudo de casos
title_full_unstemmed O papel governamental como ator essencial para a P&D de medicamentos: um estudo de casos
title_sort O papel governamental como ator essencial para a P&D de medicamentos: um estudo de casos
author Marinho,Vera Maria Costa
author_facet Marinho,Vera Maria Costa
Seidl,Peter Rudolf
Longo,Waldimir Pirró e
author_role author
author2 Seidl,Peter Rudolf
Longo,Waldimir Pirró e
author2_role author
author
dc.contributor.author.fl_str_mv Marinho,Vera Maria Costa
Seidl,Peter Rudolf
Longo,Waldimir Pirró e
dc.subject.por.fl_str_mv pharmaceutical R&D
government incentives
Taxol
topic pharmaceutical R&D
government incentives
Taxol
description The importance of natural products as a source of new high value-added drugs has, no doubt, transformed Brazilian megadiversity into one of the country's most valuable and strategic assets. Thus the rational exploration of the Brazilian flora on an economic basis should be considered as part of a national development strategy. In this respect, governmental mechanisms to stimulate regulation on the access, bioprospection and industrial use of natural products represent a crucial issue. The aim of this paper is to show how the incentives and institutional arrangements that led to one of the greatest breakthroughs in the pharmaceutical industry, the development and commercialization of the anti-cancer agent Taxol, could be applied to the Brazilian case.
publishDate 2008
dc.date.none.fl_str_mv 2008-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422008000700055
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422008000700055
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv 10.1590/S0100-40422008000700055
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Química
publisher.none.fl_str_mv Sociedade Brasileira de Química
dc.source.none.fl_str_mv Química Nova v.31 n.7 2008
reponame:Química Nova (Online)
instname:Sociedade Brasileira de Química (SBQ)
instacron:SBQ
instname_str Sociedade Brasileira de Química (SBQ)
instacron_str SBQ
institution SBQ
reponame_str Química Nova (Online)
collection Química Nova (Online)
repository.name.fl_str_mv Química Nova (Online) - Sociedade Brasileira de Química (SBQ)
repository.mail.fl_str_mv quimicanova@sbq.org.br
_version_ 1750318108331999233

Registros relacionados